Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01836666|
Recruitment Status : Completed
First Posted : April 22, 2013
Last Update Posted : February 19, 2019
How are the health related quality of life among patients with chronic pain effected by interventional pain managment?
Health related quality of life can be improved by interventional pain management both among patients with localizable pain focuses and among patients among whom no pain focuses can be found.
Health related quality of life using EQ-5D and EQ-VAS is registered at first visit, at the time of treatment for pain focuses an during the following 12 months.
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||873 participants|
|Observational Model:||Ecologic or Community|
|Target Follow-Up Duration:||1 Year|
|Official Title:||Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 31, 2017|
- EQ-VAS [ Time Frame: 1 year ]EQ-VAS is measured at first visit, at time for treatment and 3, 6 and 12 months after treatment. EQ-VAS gives a value of quality of life, and mainly used to verify the results achieved from EQ-5D since it is not possible to calculate QALY from EQ-VAS
- EQ-5D [ Time Frame: 1 year ]EQ-5D is assessed at first visit, at time for treatment and 3, 6 and 12 months after treatment. Quality of life is calculated from EQ-5D using the TTO-valuated UK value sets. This value can also be used for calculation of QALY, Quality adjusted life years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01836666
|Smärtkliniken Eques Indolor|
|Vallentuna, Sweden, 18695|
|Principal Investigator:||Johan Hambraeus, MD|